NSE has been proved to exist in bronchial epithelial cells and type II pneumocytes,5 which can be used as a distinguishing marker to identify small cell lung cancer and non-small cell lung cancer.6 Recent research7 has demonstrated NSE was also elevated in patients with benign pulmonary diseases. The gene discussed is ENO2; the disease is non-small cell lung carcinoma.